Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets

Expression of 328 ion channel genes was investigated, by in silico analysis, in 170 human melanoma samples and controls. Ninety-one members of this gene-family (i.e., about 28%) show a significant (<i>p</i> &lt; 0.05) differential expression in melanoma- vs. nevi-biopsies, taken from...

Full description

Bibliographic Details
Main Authors: Daniela D’Arcangelo, Francesca Scatozza, Claudia Giampietri, Paolo Marchetti, Francesco Facchiano, Antonio Facchiano
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/11/4/446
_version_ 1797710705082761216
author Daniela D’Arcangelo
Francesca Scatozza
Claudia Giampietri
Paolo Marchetti
Francesco Facchiano
Antonio Facchiano
author_facet Daniela D’Arcangelo
Francesca Scatozza
Claudia Giampietri
Paolo Marchetti
Francesco Facchiano
Antonio Facchiano
author_sort Daniela D’Arcangelo
collection DOAJ
description Expression of 328 ion channel genes was investigated, by in silico analysis, in 170 human melanoma samples and controls. Ninety-one members of this gene-family (i.e., about 28%) show a significant (<i>p</i> &lt; 0.05) differential expression in melanoma- vs. nevi-biopsies, taken from the GEO database. ROC (receiver operating characteristic) analysis selected 20 genes as potential markers showing the highest discrimination ability of melanoma vs. nevi (AUC &gt; 0.90 and <i>p</i> &lt; 0.0001). These 20 genes underwent a first in silico-validation round in an independent patients-dataset from GEO. A second-in silico-validation step was then carried out on a third human dataset in Oncomine. Finally, five genes were validated, showing extremely high sensitivity and specificity in melanoma detection (&gt;90% in most cases). Such five genes (namely, <i>SCNN1A</i>, <i>GJB3</i>, <i>KCNK7</i>, <i>GJB1</i>, <i>KCNN2</i>) are novel potential melanoma markers or molecular targets, never previously related to melanoma. The &#8220;druggable genome&#8222; analysis was then carried out. Miconazole, an antifungal drug commonly used in clinics, is known to target <i>KCNN2</i>, the best candidate among the five identified genes. Miconazole was then tested in vitro in proliferation assays; it dose-dependently inhibited proliferation up to 90% and potently induced cell-death in A-375 and SKMEL-28 melanoma cells, while it showed no effect in control cells. Moreover, specific silencing of <i>KCNN2</i> ion channel was achieved by siRNA transfection; under such condition miconazole strongly increases its anti-proliferative effect. In conclusion, the present study identified five ion channels that can potentially serve as sensitive and specific markers in human melanoma specimens and demonstrates that the antifungal drug miconazole, known to target one of the five identified ion channels, exerts strong and specific anti-melanoma effects in vitro.
first_indexed 2024-03-12T06:56:06Z
format Article
id doaj.art-7018037f8037463a9588c3d2cb1baa7b
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T06:56:06Z
publishDate 2019-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-7018037f8037463a9588c3d2cb1baa7b2023-09-03T00:01:55ZengMDPI AGCancers2072-66942019-03-0111444610.3390/cancers11040446cancers11040446Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular TargetsDaniela D’Arcangelo0Francesca Scatozza1Claudia Giampietri2Paolo Marchetti3Francesco Facchiano4Antonio Facchiano5Istituto Dermopatico dell’Immacolata (IDI-IRCCS), 00167 Rome, ItalyIstituto Dermopatico dell’Immacolata (IDI-IRCCS), 00167 Rome, ItalyDepartment of Anatomy, Histology, Forensic Medicine and Orthopedics, Unit of Histology and Medical Embryology, Sapienza University of Rome, 00161 Rome, ItalyMedical Oncology, Sapienza, University of Rome, 00161 Rome, ItalyDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità (ISS), 00161 Rome, ItalyIstituto Dermopatico dell’Immacolata (IDI-IRCCS), 00167 Rome, ItalyExpression of 328 ion channel genes was investigated, by in silico analysis, in 170 human melanoma samples and controls. Ninety-one members of this gene-family (i.e., about 28%) show a significant (<i>p</i> &lt; 0.05) differential expression in melanoma- vs. nevi-biopsies, taken from the GEO database. ROC (receiver operating characteristic) analysis selected 20 genes as potential markers showing the highest discrimination ability of melanoma vs. nevi (AUC &gt; 0.90 and <i>p</i> &lt; 0.0001). These 20 genes underwent a first in silico-validation round in an independent patients-dataset from GEO. A second-in silico-validation step was then carried out on a third human dataset in Oncomine. Finally, five genes were validated, showing extremely high sensitivity and specificity in melanoma detection (&gt;90% in most cases). Such five genes (namely, <i>SCNN1A</i>, <i>GJB3</i>, <i>KCNK7</i>, <i>GJB1</i>, <i>KCNN2</i>) are novel potential melanoma markers or molecular targets, never previously related to melanoma. The &#8220;druggable genome&#8222; analysis was then carried out. Miconazole, an antifungal drug commonly used in clinics, is known to target <i>KCNN2</i>, the best candidate among the five identified genes. Miconazole was then tested in vitro in proliferation assays; it dose-dependently inhibited proliferation up to 90% and potently induced cell-death in A-375 and SKMEL-28 melanoma cells, while it showed no effect in control cells. Moreover, specific silencing of <i>KCNN2</i> ion channel was achieved by siRNA transfection; under such condition miconazole strongly increases its anti-proliferative effect. In conclusion, the present study identified five ion channels that can potentially serve as sensitive and specific markers in human melanoma specimens and demonstrates that the antifungal drug miconazole, known to target one of the five identified ion channels, exerts strong and specific anti-melanoma effects in vitro.https://www.mdpi.com/2072-6694/11/4/446<i>KCNN2</i>ion channelsmelanomamiconazole
spellingShingle Daniela D’Arcangelo
Francesca Scatozza
Claudia Giampietri
Paolo Marchetti
Francesco Facchiano
Antonio Facchiano
Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
Cancers
<i>KCNN2</i>
ion channels
melanoma
miconazole
title Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
title_full Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
title_fullStr Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
title_full_unstemmed Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
title_short Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets
title_sort ion channel expression in human melanoma samples in silico identification and experimental validation of molecular targets
topic <i>KCNN2</i>
ion channels
melanoma
miconazole
url https://www.mdpi.com/2072-6694/11/4/446
work_keys_str_mv AT danieladarcangelo ionchannelexpressioninhumanmelanomasamplesinsilicoidentificationandexperimentalvalidationofmoleculartargets
AT francescascatozza ionchannelexpressioninhumanmelanomasamplesinsilicoidentificationandexperimentalvalidationofmoleculartargets
AT claudiagiampietri ionchannelexpressioninhumanmelanomasamplesinsilicoidentificationandexperimentalvalidationofmoleculartargets
AT paolomarchetti ionchannelexpressioninhumanmelanomasamplesinsilicoidentificationandexperimentalvalidationofmoleculartargets
AT francescofacchiano ionchannelexpressioninhumanmelanomasamplesinsilicoidentificationandexperimentalvalidationofmoleculartargets
AT antoniofacchiano ionchannelexpressioninhumanmelanomasamplesinsilicoidentificationandexperimentalvalidationofmoleculartargets